Optimization of experimental assay design is crucial for the overall success of any drug discovery initiative. The factors that need to be considered include: selection of the most appropriate assay ...

In writing about what attributes and skills qualify a scientist for a successful career in assay development for drug discovery, one characteristic that rarely gets discussed — but which is essential ...

Cisbio's HTRF® KinEASE™ assay for screening serine/threonine kinases now extends to tyrosine kinases (TK). The assay, developed in partnership with Millipore, uses a unique substrate containing a ...

Assays need to be specific for their research purpose, be that quantifying cellular levels of specific proteins, identification of potential new drug molecules, or quantitative measurements of levels ...

A good bioassay, like a good marriage, joins two partners in a bond and is mutually beneficial. In the case of bioassays, optimal design and development and accurate statistical analysis comprise a ...

Developing bioassay methods requires a new approach for cell and gene therapy drug development. As cell-based methods continue to evolve in support of gene therapies to assess product potency through ...

Inappropriate regulation of insulin secretion can result in extensive metabolic problems, eventually causing diabetes mellitus 1. It is extremely important that insulin is directly measured for ...

Drug resistance induced by paclitaxel and carboplatin plasmatic concentrations in lung cancer cell lines. This is an ASCO Meeting Abstract from the Markers in Cancer. This abstract does not include a ...

The mRNA Assay Development Summit is the first and only meeting to address the specific technical challenges of analytical, bioanalytical and potency assay development. This meeting will showcase ...

Bringing together technical case studies with actionable insights, the 2nd TPD Assay Development & Screening Summit returns as the only industry-dedicated conference to support in-house assay ...

Lateral flow assay applications have become increasingly diverse in a post-pandemic world, and the areas of infectious disease and oncology continue to be at the forefront. In both areas, the use of ...

Efficiency is more than just a buzzword in today's pharmaceutical industry; declining productivity and diminishing returns on investment have made it an over-arching mindset that is critical to ...